Cancer
DNA Methylation Profiles Predicting Response to Anti-PD-1-Based Treatment in Gastric Cancer Patients
In a groundbreaking study published in BMC Medicine, researchers from Guangdong, People's Republic of China, have shed light on the potential of DNA methylation as a predictive marker for the efficacy of anti-PD-1-based treatment in gastric cancer patients. By analyzing DNA methylation profiles of 99 patients treated with